Tubigon, Jesse .
HRN: 25-94-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/02/2024
10/08/2024
IV
4.5 G LOADING DOSE THEN 2.25 G
Q8
CELLLULITIS, LEFT L EG
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes